Stem Cell-Derived Vesicles Show Promise in Animal Study on Premature Ovarian Insufficiency
A new preclinical study in mice suggests that extracellular vesicles derived from human stem cells may help improve ovarian function and protein expression following chemotherapy-induced damage.
Key points
- Preclinical study investigates stem cell vesicles for premature ovarian insufficiency in mice
- Vesicle treatment partially restored hormone levels and key proteins like BMP15 and GDF9
- The research is at an early stage and requires clinical trials before human application
A recent preclinical investigation published in Nature Health Sciences explored whether extracellular vesicles extracted from human adipose-derived mesenchymal stem cells (hAD-MSC-EVs) could mitigate premature ovarian insufficiency. Conducted by researchers at the Iran University of Medical Sciences, the study examined mice in which ovarian failure was triggered using the chemotherapy drugs cyclophosphamide and busulfan. Investigators administered the vesicles via tail vein injections to evaluate their impact on hormonal levels, tissue structure, and key fertility-related proteins.
The study found that treated mice experienced partial improvements in endocrine function, marked by lowered follicle-stimulating hormone levels and higher estradiol and luteinizing hormone levels compared to untreated subjects with premature ovarian insufficiency. Histological evaluations further indicated better ovarian architecture and fewer stromal abnormalities following the treatment. Additionally, levels of crucial proteins like BMP15 and GDF9 increased in the treated animal group, reaching levels comparable to healthy controls, though corresponding messenger RNA increases remained modest.
What to know: While these findings highlight a potential pathway for future regenerative therapies, the research was performed entirely on animal models and remains at a very early stage. Readers should consult qualified medical professionals regarding personal health decisions and fertility concerns, as experimental findings do not yet translate to human clinical treatments.
Source Nature Health Sciences — nature.com/articles/s41598-026-79916-x ↗
Read next
🏃FitnessUnderstanding and Addressing Love Handles Through Lifestyle Changes
Experts clarify that spot reduction of fat is not physiologically possible, recommending a combination of calorie management and high-intensity interval training instead.
🏃FitnessCiele Releases New Woolmark-Certified Merino Winter Running Apparel
Montreal-based brand Ciele has launched its second collection of merino wool running gear, featuring performance-focused fabrics designed for cold-weather training.
🏥Public HealthPreventive Services Task Force Resumes Meetings Under New Leadership
The U.S. Preventive Services Task Force is set to reconvene this week for the first time in over a year following a significant membership overhaul by Health Secretary Ro…
❤️Conditions & CareBlood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma
Researchers have identified a specific RNA signature in blood plasma that may help predict how well lymphoma patients respond to CAR T-cell therapy.
🧠AI AnalysisUltraprocessed Diets May Impact Brain Reward Systems in Younger Adults
A Virginia Tech study suggests that individuals aged 18 to 21 may experience changes in brain reward processing after consuming ultraprocessed foods, a response not obser…
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…